Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Format: Artigo
Idioma:Russo
Publicat: «FIRMA «SILICEA» LLC 2004-12-01
Col·lecció:Российский кардиологический журнал
Matèries:
arterial hypertension
metabolic syndrome
cardioprotective effects
rilmenidine
Accés en línia:https://russjcardiol.elpub.ru/jour/article/view/2326
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars